Medical Devices Seed Investors & VC Firms

1305 firms in this list, with a median first check of $365K. 278 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NI Nimbus Synergies Inc. JRABLCMM14 people · Leads rounds	88🔒	Vancouver	CA	Pre-Seed–Series A	$250K – $2M	+ Add to CRM
RI Riverfront Ventures, LLC KBLMVRAK8 people	88🔒	Pittsburgh	US	Seed–Series A	$250K – $1M	+ Add to CRM
WA WA4STEAM AÁEAJGBO8 people	88🔒	Sant Cugat del Vallès	ES	Pre-Seed–Seed	$85K	+ Add to CRM
MI MIRAI SOUZOU 岡金2 people	88🔒	Tokyo	JP	Pre-Seed–Seed	—	+ Add to CRM
DI Diamond Edge Ventures CSNAHSKS10 people	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
GR Grey Street Partners DRHDCRDW7 people	88🔒	Melbourne	AU	Seed–Growth	$50K	+ Add to CRM
HE Heran Partners AVHVJMKV13 people	88🔒	Antwerp	BE	Seed–Series B	—	+ Add to CRM
CL Claris Ventures CSGVPPPV14 people · Follows rounds	88🔒	Torino	IT	Seed–Series A	—	+ Add to CRM
SB SBI Investment BECLDMSK6 people	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
KR KREAXI STMDSDAF11 people · Leads rounds	88🔒	Lyon	FR	Pre-Seed–Series A	$110K – $2.2M	+ Add to CRM
FA Fast Track Initiative NRKY2 people	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
RE Redesign Health NGPAAGMK13 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
CO Coddle Creek Capital CKJCJALA15 people	88🔒	Kannapolis	US	Pre-Seed–Seed	$150K – $650K	+ Add to CRM
CO Costella Kirsch BKRGJKBC6 people	88🔒	Menlo Park	US	Seed–Growth	—	+ Add to CRM
DR Draper Triangle JKMSTJZM6 people · Leads rounds	88🔒	Pittsburgh	US	Seed–Series A	$250K – $2M	+ Add to CRM
KI KIKK Capital JSBSCLFB9 people	88🔒	Roosendaal	NL	Seed–Series A	$540K – $1.6M	+ Add to CRM
EX Export and Investment Fund JBOHNJJL13 people	88🔒	Copenhagen	DK	Seed–Growth	$108K – $7.6M	+ Add to CRM
LE Leva Capital MGAHBNCM16 people	88🔒	Toronto	CA	Pre-Seed–Series A	—	+ Add to CRM
YU Yuanta Investment 강강김김20 people	88🔒	Seoul	KR	Seed–Late Stage	$1M – $15M	+ Add to CRM
AN Angelini Ventures ESPDRHTD7 people	88🔒	Rome	IT	Seed–Series A	—	+ Add to CRM
CA Catalyst Health Ventures DZJSDMJL7 people · Leads rounds	88🔒	Boston	US	Seed–Series A	$1M – $3M	+ Add to CRM
OU Outset Ventures MRSEABJG4 people · Leads rounds	88🔒	Auckland	NZ	Pre-Seed–Series B	$100K – $10M	+ Add to CRM
TI Tin Alley Ventures HCRKSWSR13 people	88🔒	Melbourne	AU	Seed–Late Stage	—	+ Add to CRM
EN Enterprise Equity COFWTS3 people	88🔒	Dundalk	IE	Seed–Series A	$81K – $1.6M	+ Add to CRM

Nimbus Synergies Inc.

VancouverPre-Seed–Series A$250K – $2M

JRABLCMM14 people

Riverfront Ventures, LLC

PittsburghSeed–Series A$250K – $1M

KBLMVRAK8 people

WA4STEAM

Sant Cugat del VallèsPre-Seed–Seed$85K

AÁEAJGBO8 people

MIRAI SOUZOU

TokyoPre-Seed–Seed

岡金2 people

Diamond Edge Ventures

San FranciscoSeed–Series A

CSNAHSKS10 people

Grey Street Partners

MelbourneSeed–Growth$50K

DRHDCRDW7 people

Heran Partners

AntwerpSeed–Series B

AVHVJMKV13 people

Claris Ventures

TorinoSeed–Series A

CSGVPPPV14 people

SBI Investment

TokyoPre-Seed–Growth

BECLDMSK6 people

KREAXI

LyonPre-Seed–Series A$110K – $2.2M

STMDSDAF11 people

Fast Track Initiative

TokyoPre-Seed–Growth

NRKY2 people

Redesign Health

New YorkSeed–Late Stage

NGPAAGMK13 people

Coddle Creek Capital

KannapolisPre-Seed–Seed$150K – $650K

CKJCJALA15 people

Costella Kirsch

Menlo ParkSeed–Growth

BKRGJKBC6 people

Draper Triangle

PittsburghSeed–Series A$250K – $2M

JKMSTJZM6 people

KIKK Capital

RoosendaalSeed–Series A$540K – $1.6M

JSBSCLFB9 people

Export and Investment Fund

CopenhagenSeed–Growth$108K – $7.6M

JBOHNJJL13 people

Leva Capital

TorontoPre-Seed–Series A

MGAHBNCM16 people

Yuanta Investment

SeoulSeed–Late Stage$1M – $15M

강강김김20 people

Angelini Ventures

RomeSeed–Series A

ESPDRHTD7 people

Catalyst Health Ventures

BostonSeed–Series A$1M – $3M

DZJSDMJL7 people

Outset Ventures

AucklandPre-Seed–Series B$100K – $10M

MRSEABJG4 people

Tin Alley Ventures

MelbourneSeed–Late Stage

HCRKSWSR13 people

Enterprise Equity

DundalkSeed–Series A$81K – $1.6M

COFWTS3 people

Data sourced from public filings and firms' own websites — see our methodology.